Purpose: Hyperpolarized carbon-13 ( 13 C) metabolic imaging is a noninvasive imaging modality for evaluating real-time metabolism. The purpose of this study was to develop and implement experimental strategies for using [1-13 C]pyruvate to probe in vivo metabolism for patients with brain tumors and other neurological diseases. Methods: The 13 C radiofrequency coils and pulse sequences were tested in a phantom and were performed using a 3 Tesla whole-body scanner. Samples of [1-
INTRODUCTION
Hyperpolarized carbon-13 ( 13 C) magnetic resonance (MR) metabolic imaging is a nonionizing, nonradioactive imaging method that can be used to measure real-time metabolism. The recent development of dissolution dynamic nuclear polarization (DNP) offers an exciting method for assessing in vivo metabolism, with a huge gain in signal intensity over the conventional 13 C MR methods (1) and enables the acquisition of 13 C metabolic imaging data with high spatial resolution in a short time (2) . One of the first applications of this technology has been to evaluate the conversion of [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] C]pyruvate to [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] C]lactate. This is particularly relevant for monitoring tumor growth and assessing response to therapy because malignant cells frequently have upregulated lactate dehydrogenase A, which is the enzyme that regulates this pathway (3, 4) . Preclinical studies that have shown promising results include the assessment of a wide range of different cancers, as well as cardiac disease, traumatic brain injury, and multiple sclerosis (5) (6) (7) (8) (9) (10) (11) (12) (13) .
The first-in-human study using hyperpolarized 13 C metabolic imaging was performed in patients with prostate cancer and was able to demonstrate the safety and feasibility of the technology in a clinical setting (14) . This has led to great interest in applying similar methods to other groups of patients and also for volunteer cardiac studies (15) . The purpose of the current study was to develop and implement hyperpolarized 13 C metabolic imaging using [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] C]pyruvate in the human brain, with the longterm goal of being able to monitor in vivo metabolism for patients with brain tumors and other neurological diseases. The 13 C coils and pulse sequences designed for this application were first tested in phantoms. Dynamic 13 C data were then obtained from patients with a prior diagnosis of glioma, which is the most common primary brain tumor in adults.
METHODS

C MR setup
All experiments were performed using a 3 Tesla (T) clinical magnetic resonance imaging (MRI) system (GE Healthcare, Waukesha, WI) with 50-mT/m, 200-mT/m/ms gradients and a multinuclear spectroscopy hardware package. The 13 C radiofrequency (RF) coil configuration comprised a bore-insertable 13 C volume coil for transmission (16) and a bilateral eight-channel phased-array coil for reception (17) (Fig. 1a,b) . The standard patient headrest holder was modified so that the subjects were comfortably stabilized in the 13 C RF coil setup, whereas the two phased-array receive coils were placed around the head (Fig. 1c ).
C coil loading tests
To investigate the effect of coil loading on the 13 C signal, a B 1 þ map was acquired using the double-angle method (18) in both unloaded and loaded scenarios using a head-shaped phantom containing unenriched ethylene glycol (HOCH 2 CH 2 OH, anhydrous, 99.8%; SigmaAldrich, St. Louis, MO). To acquire the B 1 þ map, a single-band spectral-spatial RF pulse (full width at half maximum ¼ 120 Hz) was used to selectively excite the central 13 C resonance of ethylene glycol and avoid artifacts arising from chemical shift, and then encoded with a single-shot symmetric echo-planar readout (19 ; the total scan time was 10 minutes). The B 1 map was acquired unloaded (with just the head phantom) and loaded (with the head phantom plus saline). Loading was confirmed with a change from -7 to -11 dB using a network analyzer. The flip angles over the ethylene glycol phantom were assessed as grayscale maps and histograms and compared between the loaded and unloaded cases.
Phantom tests
The phantom was scanned using the clamshell/phased array coil configuration shown in Figure 1 . For these scans, the distance between the center of the two receive coils was 17 cm. 13 C spectral data were acquired from a 2-cm slice using a dynamic 13 C 2D echo-planar spectroscopic imaging (EPSI) sequence with TR/TE ¼ 3,000/6.1 ms, 20 Â 20 mm 2 nominal in-plane resolution (20) , 10 phase encodes in the right-left (RL) direction, and a symmetric echo-planar readout in the anteroposterior (AP) direction with a constant 90 flip angle excitation.
Patient population
Eight patients who had a prior diagnosis of glioma were recruited from the neuro-oncology clinic at our institution. Table 1 summarizes their clinical parameters. They had all received multiple treatments and were being followed with MRI. An Investigational New Drug (IND) had been obtained from the U.S. Food and Drug Administration for generating the agent and implementing the clinical protocol. Patients provided written informed consent for participation in the study, which had institutional review board approval. Electrocardiogram monitoring was performed at baseline and within 1 hour after the pyruvate injection. Clinical follow-up assessments were performed at 24 hours.
Sample formulation and polarization
For patients scans, the hyperpolarized [1-
13 C]pyruvate was produced using a SPINlab (General Electric, Niskayuna, NY) DNP polarizer that is adjacent to the 3T MR scanner. The pharmacy kit (fluid path) was filled in an ISO 5 environment utilizing an isolator (Getinge Group, Getinge, France) and a clean bench laminar flow hood. The mixture used for polarization comprised 1.432 g of [1- 13 C]pyruvic acid (MilliporeSigma, Miamisburg, OH) and 28 mg of trityl radical (GE Healthcare, Oslo, Norway). The fluid path was then loaded into one of the available channels in the SPINlab polarizer. After approximately 2.5 hours of microwave irradiation at 140 GHz, the mixture of [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] C]pyruvic acid and trityl radical was dissolved in sterile water and forced through a filter that removed trityl radical to a level below 3 mM. The solution was then collected in a receiver vessel, neutralized, and diluted with a sodium hydroxide tris(hydroxymethyl)aminomethane/ethylenediaminetetraacetic acid buffer solution. The receive assembly that accommodates quality-control (QC) processes provided rapid measurements of pH, temperature, residual electron paramagnetic agent (EPA) concentration, volume, pyruvate concentration, and polarization level. The final step in the automated compounding procedure was for the drug product to be passed through a sterilizing filter (0.2 mm; ZenPure, Manassas, VA) within the SPINlab QC system immediately before being collected in a sterile Medrad syringe.
Once the preparation was complete, a sterile filter integrity test was performed in parallel with the pyruvate solution being transported to the MRI scan room and being set up on a power injector. Successful QC and filter integrity tests were required before the hyperpolarized pyruvate doses were released for patient injections. The acceptance criteria for the hyperpolarized pyruvate injection were: 1) polarization > ¼15%; 2) pyruvate concentration between 220 and 280 mM; 3) EPA concentration < ¼3.0 mM; 4) pH between 5.0 and 9.0; 5) temperature between 25.0 and 37.0 C; 6) volume > 38 mL; and 7) filter integrity passes the bubble point test at 50 psi. Following approval from the pharmacist, a sample corresponding to a dose of 0.43 mL/kg from the approximately 250-mM pyruvate solution was delivered to the subject at a rate of 5 mL/s. After completion of pyruvate injection, a further 20 mL of sterile saline was injected at a rate of 5 mL/s. The polarization, QC, and timing parameters are summarized in Table 1 .
Imaging protocol for patient study
Before the start of each examination, patients were monitored to establish their baseline vital signs and an intravenous catheter was placed in their antecubital vein. After positioning in the scanner with the 13 C coil setup covering as much of the lesion as possible, T 2 -weighted fast spin echo images (TR/TE ¼ 60/4,000 ms, 26-cm FOV, 192 Â 256 matrix, 5-mm slice thickness, and number of excitations ¼ 2) were acquired with the 1 H body coil to provide an anatomical reference. Frequency calibration was performed with the 13 C coils using the sealed standard that is housed within one of the eight-channel phased array elements and contains 1 mL of 8 M of 13 Curea. Once the appropriate scan parameters had been defined, the operators of the SPINlab system started the dissolution process. When the pharmacist had approved the results provided by the QC system and filter integrity tests, the pyruvate solution and saline flush were administered into the patient. Dynamic 13 C data were acquired starting 5 seconds after the end of the saline injection from an axial slab that was centered over the anatomical lesion.
The acquisition parameters for the 13 C data are summarized in Table 2 . For patient 1, the dynamic data were acquired from a 30-mm axial slice with a 10 flip angle, TR/TE ¼ 3,000/35 ms, 3-second temporal resolution, and 40 total time points. For 5 patients, 2D-localized dynamic EPSI data were obtained from a 20-mm axial slice with a constant 10 flip angle, 24 total time points, either 10 or 12 phase encodes in the RL direction, and a symmetric echo-planar readout in the AP direction (20) . The TR/TE was 130/6.1 ms, the time resolution was 3 seconds, and the nominal in-plane spatial resolution was either 15 Â 15, 18 Â 18, or 20 Â 20 mm 2 (21) . The EPSI readout contained the following parameters: spectral resolution ¼ 10.4 Hz, EPSI duration ¼ 96.4 ms, spectral bandwidth ¼ 543 Hz, minimum resolution ¼ 4.8 mm, signal-to-noise ratio (SNR) efficiency ¼ 0.94. Similar dynamic EPSI data were obtained for the other 2 patients, but with an excitation scheme that utilized a multiband RF pulse and progressively increasing flip angle scheme (22, 23) . These flip angle schemes were designed to efficiently use the magnetization in several ways: use lower flip angles on pyruvate to increase the magnetization available for metabolic conversion, evenly distribute magnetization throughout the acquisition by accounting for T 1 decay, prior RF excitations, and metabolic conversion; and use all available magnetization by the end of the experiment (23) . The plot of pyruvate, lactate, and bicarbonate flip angles across all excitations are shown in Supporting Figure S1 . At the completion of the 13 C examination, patients were taken out of the scanner for postinjection monitoring and then brought back for a subsequent standard 1 H MR examination that was obtained with a conventional head coil.
Data analysis
The slice-localized dynamic 13 C data were processed with MATLAB (version 7.0; The MathWorks, Inc., Natick, MA). Individual free induction decays were apodized with a 10-Hz Gaussian filter in the time domain and Fourier-transformed to produce 13 C spectra at each time point. The 2D EPSI dynamic 13 C data were processed with software developed in our laboratory including the Spectroscopic Image Visualization and Computing (SIVIC) package (24, 25) . The odd and even echoes of the symmetric EPSI readout were separated and processed by the following steps: 1) apodization by a 10-Hz Gaussian filter in the time domain; 2) correction of timing delays between spatial k-space samples; 3) ramp samples were gridding onto a uniform grid; 4) Fourier-transformed; and 5) combined with linear phase added to correct for timing differences between the even and odd data. This produced a time series of spectroscopic imaging data for each coil element. In order to correct for the aliased bicarbonate chemical shift, the second set of data were generated by demodulating the raw data at a different frequency before reconstruction. The coil combination algorithm used for the slice select and initial review of the 2D EPSI data utilized a magnitude sum of squares algorithm. Subsequent quantitative analysis of the 2D EPSI data utilized a linear combination of phase-sensitive spectra from different receive coils with phases and weights determined from the intensity of the pyruvate signal from the time point at which it was at a maximum. In addition to the dynamic analysis, a single spectral array was calculated by summing the time series on a voxel-by-voxel basis. Peak intensities for lactate and pyruvate were estimated from the spectral array that was reconstructed at the original reference frequency, and the peak intensities for bicarbonate were estimated from the array that was reconstructed at its frequency. To perform this analysis, each array was baseline subtracted, then frequency and phase corrected using methods described previously for H-1 data (25) . SNRs were calculated as the peak height over the standard deviation from regions in the spectra without any metabolic signal.
To relate the 13 C data with anatomical features, the fluid attenuation inversion recovery (FLAIR) and T 1 -weighted post-Gd (gadolinium) images obtained from the subsequent 1 H imaging examination were aligned with the body-coil T 2 -weighted images. A mask corresponding to brain parenchyma was obtained using the FSL brain extraction tool. The T 2 lesion was defined using manual segmentation. This was then subtracted from the mask of brain parenchyma in order to unambiguously define regions of normal-appearing brain (NAB) tissue. The following criteria were used to classify the voxels for NAB or T 2 lesion: 1) Voxels from NAB were defined as being at least 80% within the brain, having no overlap with the T 2 lesion, and having lactate SNR greater than 10.0 and bicarbonate SNR greater than 5.0; 2) for the T 2 lesion, the voxels that were overlapped by more than 30% with the T 2 lesion and had lactate SNR greater than 10.0 were chosen. Figure 2A shows the results from the 13 C coil loading test. The B 1 þ field measured using the double-flip-angle method (26) appeared to be similar between the unloaded and loaded conditions. The calculated flip angles from the flip angle maps and histograms were 28 6 7 (n ¼ 3) and 26 6 8 (n ¼ 3) for the unloaded and loaded condition, respectively. This meant that the power requirements did not change between the loaded and unloaded conditions, and a power calibration on the head phantom could be used for patient studies. Based on these results, the ethylene glycol phantom shown was used to calibrate the transmit gain for the 13 C sequence before subjects were placed on the scanner.
RESULTS
C coil loading test
Phantom data
The 13 C coils and sequences detected 13 C signal from the phantom (Fig. 2b) , but with 3-to 4-fold lower intensity in the center of the FOV attributed to the reception profiles of the receive coil elements. This is in agreement with previous tests done in a study that focused on evaluating data from the brain of a nonhuman primate (21) .
Patient data
All patients tolerated the pyruvate injection well, and no adverse effects were observed or reported subsequently. Levels of polarization and QC parameters obtained are presented in Table 1 and were well within the specifications defined in the IND. The mean EPA concentration was 0.99 mM (range, 0.2-3.0), pyruvate concentration was 236 mM (range, 221-249), polarization was 37% (range, 32-43), and pH was 7.5 (range, 7.0-8.1). The mean scan start time measured from the start of dissolution was 88 seconds (range, 74-114). Figure 3 shows the slice-localized 13 C dynamic data from a 30-mm-thick axial slice for subject 1. The location of the slice is defined on the sagittal image in Figure 3A . The 13 C dynamic spectra are represented as a stack plot in Figure 3B . They are displayed in magnitude mode and were acquired with a time resolution of 3 seconds. SNRs of pyruvate, lactate, and bicarbonate are plotted as a function of time in Figure 3c . The pyruvate signal at 173 parts per million (ppm) reached a maximum with SNR of 3,266 at approximately 15 seconds from the start of the data acquisition, whereas the lactate signal at 185 ppm reached a maximum SNR of 293 at 24 seconds, which was 9 seconds later. The pyruvate signal decreased rapidly from the maximum peak. Pyruvatehydrate was observed as a peak lying between the pyruvate and lactate resonances, but had relatively low signal amplitude (Fig. 3b) . Signal from bicarbonate was detected at approximately 162 ppm and had lower intensity than lactate (Fig. 3c) .
The peak time point and maximum voxel SNR for the 2D EPSI dynamic data are shown in Table 2 . Although the time at which the pyruvate delivery was a maximum varied from 3 to 9 seconds, the additional delay for reaching the highest lactate was 9 seconds for 6 of the 7 patients and 6 seconds for 1 patient. As expected, the maximum SNRs was lowest for patient 3, for whom the time to injection was the longest at 114 seconds, and the second lowest for patient 6, for whom the number of phase encodes was increased and the voxel resolution reduced. The maximum SNR for pyruvate was lower in patients 7 and 8 because of the multiband excitation and flip angle scheme that was used, but this scheme resulted in higher levels of lactate and bicarbonate. Taken as a whole, these results confirmed that hyperpolarized pyruvate was able to cross the blood-brain barrier and was converted to lactate with a similar time course between subjects.
The acquisition of the 2D EPSI dynamic 13 C metabolic imaging data made it possible to investigate spatial variations in metabolism. Figure 4 shows reference anatomical images and spectra from multiple time points for voxels in the T 2 lesion (black box) and voxels from contralateral brain tissue (white box) for patient 2. The voxels from the T 2 lesion show peaks from lactate, pyruvate-hydrate, and pyruvate, whereas the voxels from contralateral NAB have peaks from lactate, pyruvatehydrate, bicarbonate, and pyruvate. Note that because of the reduced spectral bandwidth with EPSI, the bicarbonate peak wrapped into a location between pyruvatehydrate and pyruvate peaks ($179 ppm). In both cases, lactate peaks were relatively high in the time period between 12 and 24 seconds after the start of data acquisition. The spectra in Figure 5 are from voxels in NAB for patients 3 to 6 at time points where the lactate was highest. Although it is difficult to compare intensities because of variations in the reception profile of the coil, it can be seen that the relative levels of lactate and pyruvate were similar to those for patient 2, but that the bicarbonate peak is absent for the spectrum from patient 6. This may be attributed to the smaller voxel size and the use of 12 rather than 10 phase encodes for data acquisition. Table 3 shows metabolite intensities and ratios for spectra from patients 2 to 8 that were summed over all time points. In all cases, the maximum lactate and bicarbonate SNRs were higher in the NAB than in the T 2 lesion. Of particular interest is that the 2 patients whose data were acquired with the multiband variable flip angle excitation scheme (patients 7 and 8) have much higher maximum SNR for bicarbonate in NAB (28.8 and 34.1) than patients 2 to 6, but, even in this case, the maximum SNR of bicarbonate from the T 2 lesion was close to or lower than the level considered to be detectable (4.0 and 5.4). The maximum SNR of lactate in the T 2 lesion was variable between patients, which reflects not only differences in its location relative to the sensitivity profile of the RF coils, but also was attributed to differing contributions from tumor versus treatment effects. The mean lactate/pyruvate for voxels in NAB that had sufficient SNR to provide good estimates of metabolite levels for patients 2 to 6 ranged from 0.18 to 0.38, whereas for patients 7 and 8 they were 0.98 and 0.84. The corresponding values for bicarbonate/pyruvate were 0.06 to 0.15 versus 0.32 and 0.37. The increased metabolite ratios in patients 7 and 8 are likely a result of the multiband variable flip angle scheme used only in these patients. Figure 6 shows a T 1 post-Gd image, maps of pyruvate, lactate, and bicarbonate SNR, and spectral arrays that were summed over all time points for patient 2. The low signal in the center of the brain is attributed to both the coil reception profile and the lower tissue content on voxels overlapping with the ventricles. Figure 7 illustrates representative data from patient 2 and patient 8, showing anatomical images as well as color overlays of lactate/pyruvate and bicarbonate/pyruvate on the post-Gd T 1 -weighted anatomical images. Despite the differences in acquisition parameters and ratio values, both data sets showed substantial conversion of pyruvate to lactate in NAB and a lack of bicarbonate in the T 2 lesion. Patient 2 had lactate/pyruvate in the T 2 lesion with mean value of 0.30 compared with 0.38 in their NAB, whereas patient 8 had mean lactate/ pyruvate of 0.41 within the T 2 lesion compared with 0.84 in their NAB.
FIG. 4.
Temporal changes in spectra from the highlighted voxels in (a) NAB and (b) the T 2 lesion from patient 2. The spectra with peaks shaded in gray are from the data reconstructed at the acquired reference frequency, and the peaks shaded in black represent the data reconstructed at the bicarbonate frequency. The spectra shown are from time at 0, 6, 12, 18, and 24 seconds from the start of data acquisition. The highest pyruvate and pyruvate-hydrate occur at 6 seconds, whereas the highest lactate occurs at time point 15 seconds. It can be seen that there are lactate and bicarbonate peaks in NAB and lactate peaks in the T 2 lesion during the period of 9 to 24 seconds. The chemical shift range is 186.46 to 169.61ppm for all spectroscopic voxels. The intensity scales are arbitrary, but were kept the same for all spectra.
DISCUSSION
This study demonstrated the safety and feasibility of using hyperpolarized 13 C metabolic imaging for measuring real-time metabolism in the human brain utilizing pyruvate that is transported across the blood-brain barrier by monocarboxylic transporter MCT 1 (27) . The slicelocalized and 2D EPSI pulse sequences and 13 C coils were first tested in a head-shaped phantom. The spatial variation in signal intensity that was observed in the phantom data demonstrated the anticipated variation due to the reception profile of the 2 four-channel paddle array coils, with a 3-to 4-fold reduction in intensity in the center of the phantom versus voxels within 2 to 4 cm of the lateral edges. The focus of these first patient studies was to determine the safety and feasibility. Another focus of the initial study was to define the time course of delivery and metabolism of hyperpolarized [1- 13 C]pyruvate in both the anatomical lesion and normal appearing brain, as opposed to seeking information about potential diagnostic capabilities at this early stage. The SPINlab polarizer and the associated QC system provided pyruvate solution with an appropriate pH, temperature, EPA concentration, and polarization level. The average polarization was of 37% which was approximately 2-fold higher than prior polarizations achieved using pre-clinical polarizers (12) . This can be explained by the low sample vial temperature in the SPINlab (approximately 0.8 K) compared to the preclinical system (approximately 1.35 K) (28) and its higher magnetic field (5T as opposed to 3.35T). Although the dissolution and The spectra with peaks shaded in gray are from the data reconstructed at the acquired reference frequency and the peaks shaded in black represent the data reconstructed at the bicarbonate frequency. The relative levels of pyruvate are similar, but the lactate is slightly lower in all patients shown and the bicarbonate is not detectable for patient 6, for whom the acquisition had the smallest voxel size 1.5 Â 1.5 Â 2 cm and 12 rather than 10 phase encodes. The chemical shift range is 186.46 to 169.61 ppm for all spectroscopic voxels. The intensity scales are arbitrary and were manually set to have similar pyruvate intensity levels between subjects. Maximum SNR and mean ratios are from voxels that were either: normal appearing brain (NAB)-at least 80% from NAB, not overlapping with the T 2 lesion and with lactate SNR >10.0 and bicarbonate SNR > 5.0; or T 2 lesion-overlapped by more than 30% with the T 2 lesion with lactate SNR >10.0 (n ¼ number of voxels satisfying criteria). Note that the multiband, variable flip angle scheme used for patients 7 and 8 will alter the metabolite ratios. lac, bicarb, and pyr represent lactate, bicarbonate, and pyruvate, respectively. n/a, not applicable.
ensuing QC procedure, which lasted approximately 37 seconds, extended the time from the start of dissolution to the scan (mean time of 88 seconds) compared to the preclinical system (typically 10-15 seconds), the high polarization levels generated from the SPINlab system were important for providing 13 C data from human brain FIG. 6 . A post-Gd T 1 -weighted image, color maps of integrated pyruvate, lactate, and bicarbonate SNR and arrays of summed spectra from patient 2. The spectra with peaks shaded in gray are from the data reconstructed at the acquired reference frequency, and the peaks shaded in black represent the data reconstructed at the bicarbonate frequency. The lactate and pyruvate peak intensities were determined from the former gray spectra and the bicarbonate peak intensities from the black spectra. The proposed coil setup with the clamshell transmit and the eight-channel bilateral receive arrays allowed the acquisition of 13 C signals across the majority of the brain, but with significantly lower SNR in central regions. The low SNR in the center of the brain was accentuated by reduced signal in the ventricles. 13 C metabolite ratio image overlays estimated from 2D EPSI dynamic data acquired at 2 cm in plane resolution and 2-cm slice thickness from 2 patients with treated glioblastoma multiforme. The differences in scales for the color overlay images are attributed to the single-band constant flip angle excitation scheme utilized for patient 2 and the multiband variable flip angle excitation scheme used for patient 8. Note that, in both cases, the bicarbonate/pyruvate was higher in regions of NAB. The patient in the upper images (patient 2) had progressive tumor at the time of this exam, and the patient in the lower images (patient 8) was not characterizing as progressing until subsequent follow-up scans. lac/pyr and bicarb/pyr represent lactate/pyruvate and bicarbonate/pyruvate, respectively. with high SNR. For patient 3, the pH was measured manually by the pharmacist, which extended the time from dissolution to data acquisition to 114 seconds and resulted in the maximum SNR of pyruvate and lactate being lower compared to other data.
FIG. 7. Anatomical and interpolated hyperpolarized
The coil setup with the clamshell transmit and the eight-channel bilateral receive arrays allowed the acquisition of 13 C signals across the majority of the brain, but with significantly lower SNR in the central regions. This was expected based upon knowledge of the reception profile of the paddle coils and results from the phantom experiments, but was accentuated by the reduced signal in voxels overlapping the ventricles. Care must be taken when using this experimental setup to avoid the misinterpretation of the variation in the levels of metabolite signals from different parts of the brain. When the SNR is adequate, the use of metabolite ratios provides a more meaningful within-subject comparison. One approach to correct for this is to integrate all of the metabolic signals on a voxel-by-voxel basis for each coil and to use these as estimates of the coil sensitivity maps. Although this provides a simple approach that does not rely upon external standards, it may overestimate parameters in regions with high contributions from the vasculature or when metabolite T 1 s are very different. Other methods include the use of coil reception profiles that are estimated from numerical simulations or maps obtained from phantom studies (29) , as well as the development of 13 C volume or multichannel head coils that provide more homogenous reception profiles.
The time course of signals from the slice-localized and 2D EPSI 13 C data showed a similar pattern, with the maximum lactate appearing between 6 and 9 seconds after the maximum pyruvate for all patients. Although there may be differences in the arrival time of the pyruvate based upon heart rate and local vasculature, the values observed for the 2D EPSI data were within one time point of the mean value and were similar to findings from our previously reported studies in nonhuman primates (21) . Note that the flip angle excitation scheme employed for patients 2 to 6 was the simplest possible (uniform across the spectrum and constant of 10 for each excitation) and the number of phase encodes was similar (10 for patients 2-5, 7, and 8 and 12 for patient 6). Although this does provide a clear picture of the dynamic processes associated with delivery and metabolism of pyruvate within the brain, it uses more of the available magnetization during the early time points than the multiband, variable flip angle scheme used for patients 7 and 8, which began with flip angles of 1.2 for pyruvate and 8.7
for lactate (22, 23) . The higher SNR and ratio values that were obtained for lactate and bicarbonate using the more complex acquisition scheme indicates that it should be considered for future studies that require improved spatial resolution and increased coverage. The incorporation of compressed sensing reconstruction (2, 30, 31) and frequency-specific echo planar imaging (19) are also likely to be important for obtaining 3D 13 C metabolic imaging data from the brain. The bicarbonate signals observed in the patient studies suggest that hyperpolarized 13 C pyruvate may be useful for probing mitochondrial metabolism. Although the SNR of bicarbonate peaks was relatively small compared to pyruvate and lactate, it was detected in NAB for 7 of 8 subjects. Of particular interest is that it was clearly present in voxels from contralateral brain, but absent in voxels from the T 2 lesion for patients 2, 7, and 8, whose scans showed sufficiently high enough SNR and had large enough lesions to provide definitive results. This differential is of interest for future studies and needs to be considered in pulse-sequence design. The relatively low metabolite signals in voxels overlapping with the T 2 lesion from patients 3 to 6 are consistent with them either being in regions with low reception profile or corresponding mainly to treatment effects rather than residual or recurrent tumor. None of these voxels were enhancing on corresponding post-Gd T 1 -weighted images or were in portions of the lesion that were found to progress in subsequent scans. Although the relatively high conversion of pyruvate to lactate in NAB meant that there was not a clear differential for voxels in the T 2 lesion and surrounding brain for patient 2, who was the only subject with clinical status defined as progressive tumor and had high enough lactate SNR in tumor, it does suggest that this technique may be of interest for studying changes in metabolism associated with other neurological diseases.
The purpose of this paper was to report upon initial patient studies and to introduce the experimental setup that was designed for the acquisition of 13 C data from the human brain. Although a relatively small group of patients were included, the time course of changes in metabolite levels and the appearance of lactate and bicarbonate in NAB were consistent between subjects and provide a basis for designing future, more advanced data acquisition schemes and experimental setups. The observation of substantial conversion of pyruvate to lactate in normal brain is in contrast to our previous results in studies from normal rats and nonhuman primates (2, 12, 21) , where the conversion of pyruvate to lactate was relatively low. In our previous rodent studies that used similar experimental conditions, the bicarbonate signal was not detected (12, 13) ; however, there have been several other reports in rats that have demonstrated the detection of bicarbonate in normal brain as well as in glioma (32) (33) (34) . Whether this was attributed to differences in brain metabolism between humans and other species or because of the anesthesia (35) is unclear. Of interest for evaluating patients with brain tumors is that no bicarbonate was detected in lesions corresponding to recurrent tumor, but that the ratios of lactate/pyruvate in T 2 lesion were similar to or lower than the lactate/pyruvate in NAB. Further technical studies are required to optimize data acquisition parameters for the brain to provide 3D coverage and finer spatial resolution. This will be important for using hyperpolarized 13 C agents to characterize metabolism in normal gray and white matter, as well as detecting changes associated with brain tumors and other types of pathology.
CONCLUSIONS
Experimental strategies for implementing hyperpolarized 13 C metabolic imaging in the human brain have been developed, and initial patient studies have confirmed C-bicarbonate, in a time frame that can be measured using the pulse sequences and RF coils designed for this study. Although additional optimization is required, these initial findings support further investigation of the technology in patients with brain tumors and other neurological diseases.
